Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D Smith,1 Lynn W Maines,1 Staci N Keller,1 Vered Katz Ben-Yair,2 Reza Fathi,2 Terry F Plasse,2 Mark L Levitt2 1Apogee Biotechnology Corporation, Hummelstown, PA, USA; 2RedHill Biopharma LTD, Tel Aviv, IsraelCorrespondence: Charles D Smith, Apogee Biotechnology Corporation, 1214 Research Blvd...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2022-07-01
|
| Serie: | Drug Design, Development and Therapy |
| Soggetti: | |
| Accesso online: | https://www.dovepress.com/recent-progress-in-the-development-of-opaganib-for-the-treatment-of-co-peer-reviewed-fulltext-article-DDDT |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|